Fagerholm, R., & Brenner, H. (2017). TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer. OncoTarget, 8(11), . https://doi.org/10.18632/oncotarget.15110
Chicago-Zitierstil (17. Ausg.)Fagerholm, Rainer, und Hermann Brenner. "TP53-based Interaction Analysis Identifies Cis-eQTL Variants for TP53BP2, FBXO28, and FAM53A That Associate with Survival and Treatment Outcome in Breast Cancer." OncoTarget 8, no. 11 (2017). https://doi.org/10.18632/oncotarget.15110.
MLA-Zitierstil (9. Ausg.)Fagerholm, Rainer, und Hermann Brenner. "TP53-based Interaction Analysis Identifies Cis-eQTL Variants for TP53BP2, FBXO28, and FAM53A That Associate with Survival and Treatment Outcome in Breast Cancer." OncoTarget, vol. 8, no. 11, 2017, https://doi.org/10.18632/oncotarget.15110.